In addition, the strong linkage disequilibrium between LRP5 rs556442 and other polymorphisms may affect the effect of LRP5 rs556442 on the risk of NAFLD, CHD, and NAFLD + CHD. This evidence concerns the gene LRP5 and metabolic dysfunction-associated steatotic liver disease.